Marksans Pharma to Acquire Netherlands-Based QliniQ BV
MM Desk
5 June, 2026
Marksans Pharma Limited (NSE: MARKSANS | BSE: 524404), a global pharmaceutical company focused on regulated
Marksans Pharma Limited (NSE: MARKSANS | BSE: 524404), a global pharmaceutical company focused on regulated
Marksans Pharma Ltd has reported its highest-ever annual revenue, EBITDA and profit after tax for
Marksans Pharma Limited has received final approval from the United States Food and Drug Administration